Archive for September 2019
Surviving sepsis: Beth’s story
There are some unspoken rules in the TV news business, like always assume the microphone is hot and stay out of other photographers’ shots. Another is to keep the story succinct. Even on a one-hour broadcast, a general report may last a minute and a half, possibly two. But there are times when it’s necessary…
Read MoreQ&A: BARDA Director Rick Bright Discusses New Programs, Focus on Diagnostics
Rick Bright joined the Biomedical Advanced Research and Development Authority in 2010 following a scientific career addressing influenza at the US Centers for Disease Control and Prevention and at PATH, plus a stint in industry at a vaccine development firm. Now a 12-year-old agency, BARDA was always intended to be nimble and innovative. Lately, however,…
Read MoreExecs On The Move: Marketing And Sales Appointments At Quest, SomaLogic And Immunexpress
Quest Diagnostics and SomaLogic, a protein biomarker discovery and diagnostics company, will each bring on a new chief commercial officer; Immunexpress, a sepsis diagnostics firm, hired a VP for market development and commercial operations; and more.
Read MoreImmunexpress Appoints Jane Papadaki Markley as VP of Market Development and Commercial Operations
The addition represents the development of a global commercial framework in preparation for SeptiCyte™ RAPID launch Immunexpress, Inc. today announced that Jane Papadaki Markley has joined the company’s Executive Team as Vice President of Market Development and Commercial Operations. “Jane’s impressive ability to incorporate the commercial perspective into development strategies will be influential in our upcoming launch…
Read More